NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit
U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention
Avastin Improves PFS In Advanced Breast Cancer
Preoperative Drug Combo Benefits HER-2 Breast Cancer
Combination Radiation/Vaccine May Benefit Some Patients
“Inoperable” Prostate Cancer May Be Operable, Curable
Benefit Seen In Novel Drug That Treats Gleevec Resistance
NCI’s Rosenberg Confirms 2002 Immunotherapy Results
NCI-Approved Clinical Trials
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death
